Evidence map›Paper›PMID 37938162›Full record

ArticleAmerican journal of respiratory and critical care medicine2024

Routine Metagenomics Service for ICU Patients with Respiratory Infection.

Themoula Charalampous, Adela Alcolea-Medina, Luke B Snell, Christopher Alder, Mark Tan, Tom G S Williams, Noor Al-Yaakoubi, Gul Humayun, Christopher I S Meadows, Duncan L A Wyncoll and 15 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Clinical metagenomics: a call to action.Intensive care medicine · 2026
    Article
  3. Microbiome Profiling Reveals Prognostic Heterogeneity inmedRxiv : the preprint server for health sciences · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 2 countries.

Themoula CharalampousCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Adela Alcolea-MedinaCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Luke B SnellCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Christopher AlderCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Mark TanCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Tom G S WilliamsDepartment of Infectious Diseases and.
Noor Al-YaakoubiCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Gul HumayunCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Christopher I S MeadowsFaculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Duncan L A WyncollCritical Care Directorate, Guy's and St Thomas' NHS Foundation Trust, London, England.
Richard PaulCritical Care Directorate, Guy's and St Thomas' NHS Foundation Trust, London, England.
Carolyn J HemsleyDepartment of Infectious Diseases and.
Dakshika JeyaratnamDepartment of Infectious Diseases and.
William NewsholmeDepartment of Infectious Diseases and.
Simon GoldenbergDepartment of Infectious Diseases and.
Amita PatelCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Fearghal TuckerInfection Sciences, Synnovis, London, United Kingdom.
Gaia NebbiaDepartment of Infectious Diseases and.
Mark WilksLondon School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.
Meera ChandUK Health Security Agency, London, United Kingdom; and.
Penelope R CliffInfection Sciences, Synnovis, London, United Kingdom.
Rahul BatraCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Justin O'GradyOxford Nanopore Technologies, Oxford, United Kingdom.
Nicholas A BarrettCritical Care Directorate, Guy's and St Thomas' NHS Foundation Trust, London, England.
Jonathan D EdgeworthCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences and.
Guy's and St Thomas' NHS Foundation Trust · GBKing's College London · GBSt Thomas' Hospital · GBBiology of Infection · FROxford Nanopore Technologies (United Kingdom) · GBQueen Mary University of London · GBUK Health Security Agency · GB

Funding

Medical Research Council MC_PC_19041Medical Research Council MR/T005416/1Medical Research Council MR/W025140/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsRespiratory Tract InfectionsHumansIntensive Care UnitsLondonPilot ProjectsAnti-Infective Agents

Identifiers

PMID37938162
PMCPMC10806431
OpenAlexW4388489356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.